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undecenoxycarbonyl-L-leucinate; poly-L-SUCLS, polysodium N-undecenoxycarbonyl-L-
leucine sulfate; poly-L-SUCV, polysodium N-undecenoxycarbonyl-L-valinate; poly-L-SUL, 
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ammonium -cyclodextrin; SBCD, sulfated -cyclodextrin; SBEBCD, sulfobutyl ether β-
cyclodextrin; SuccGCD, succinyl- -cyclodextrin; TMABCD, 2-
hydroxypropyltrimethylammonium- -cyclodextrin; TMBCD, heptakis(2,3,6-tri-O-methyl)-β-
cyclodextrin. 
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ABSTRACT 
 
This review article addresses the developments and applications of capillary electromigration 
methods coupled on-line with mass spectrometry for chiral analysis. The multiple 
enantiomeric applications of this hyphenated technology are covered including chiral analysis 
of drugs, food compounds, pesticides, natural metabolites, etc., in different matrices such as 
plasma, urine, medicines, foods, etc. This work intends to provide an updated overview 
(including works published till September 2009) on the principal chiral applications carried 
out by CZE-MS, CEC-MS and MEKC-MS, discussing their main advantages and drawbacks 
in all their different areas of application as well as their foreseeable development in the non-
distant future.  
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1. INTRODUCTION 
 
In the past thirty years, there has been a growing interest in the separation and quantification 
of enantiomers from many different fields including pharmaceutical, clinical, environmental 
and food analysis. Thus, chiral analysis is nowadays required by pharmaceutical regulatory 
authorities due to the different therapeutic effects that enantiomers can have. Whereas one can 
have the desired biological activity, the other can have none or even adverse effects. Also, in 
food analysis, enantioselective separations can be used e.g., for identifying adulterated foods 
and beverages or monitoring microbiological contamination [1].   
 
Numerous analytical techniques have been developed so far to respond to these requirements 
[2-4]. In this regard, the use of capillary electrophoresis (CE) has shown impressive 
possibilities for the enantioselective separation of chiral compounds as can be deduced from 
the large number of reviews published on this topic in the last 10 years (see Table 1) [5-29]. 
CE exhibits high efficiency, fast migration times and needs low volume of samples (few 
nanoliters). Moreover, since the chiral selectors are mixed with the background electrolyte 
(BGE) in chiral CZE and MEKC or forming the stationary phase in chiral-CEC, it is easy to 
try numerous chiral selectors at different concentrations. The volume in the column is very 
low and makes affordable to try expensive chiral selectors. The main disadvantage is the 
relatively poor limit of detection of CE.  
 
On the other hand, analysis of chiral compounds in real samples can be extremely 
problematic, electropherograms can be very complex, and co-migration becomes frequent and 
difficult to detect giving rise to unwanted matrix effects. Besides, the analytes of interest will 
frequently need to be accurately measured at very low concentrations. Therefore, to obtain the 
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required robustness and sensitivity in a reasonable time, all steps of the analytical method 
should be optimized. Those steps include the sample preparation, the chiral separation and the 
detection [3].  
 
One of the major breakthroughs of CE for the determination of chiral analytes in real matrices 
has been its on-line coupling to MS using electrospray ionization interfaces (ESI). MS allows 
an unambiguous assignment of the different electrophoretic peaks while MS/MS spectra can 
also give information about the structure of the analytes. Therefore, the combination of chiral-
capillary electromigration methods with mass spectrometry brings about a very powerful 
hyphenated technique able to provide high sensitivity and selectivity, while it allows solving 
the identification problems associated with unknown chiral compounds in real samples. 
Interestingly, it was believed that the development of modern MS, MS/MS and MS
n
 
instruments able to provide everyday better accuracy and mass resolution would permit a 
direct analysis without the need of a separation and/or sample pre-treatment. However, it has 
been demonstrated to be unrealistic and more in the case of chiral analysis, where both 
enantiomers will have the same mass spectra and, therefore, baseline separation will have to 
be obtained before the MS detection. Moreover, presence of co-migrating species can reduce 
the MS signal and give errors on the measure (matrix effect) [30]. These limitations can be 
overcome by using hyphenated techniques as CE-MS.   
 
In spite of all these advantages, it has been repeatedly indicated that one of the main problems 
during any chiral analysis by CE-MS is the contamination of the ionization source induced by 
the chiral selector used in the BGE (typically nonvolatile cyclodextrin (CD) derivatives) [31]. 
As a result, different procedures have been developed in order to overcome this limitation, as 
reviewed by several authors (see Table 1). Thus, as will be discussed below, different 
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solutions have been proposed including the use of chiral-CEC-MS in which the fixed chiral 
stationary phase does not move within the capillary avoiding any interference with the 
ionization source. However, the peak efficiency obtained by using CEC-MS is usually low, 
while its robustness still needs to be improved. On the other hand, in CZE-MS and MEKC-
MS is common the use of charged CDs, macrocyclic antibiotics, and/or the most frequent 
partial-filling technique (PFT), being their main goal to prevent the entrance of the chiral 
selector into the ionization source. In general, these approaches are able to overcome the MS 
contamination problem although they result in a different selectivity, lower resolution, and 
lower peak capacity than in normal chiral CZE or MEKC. 
 
2. SCOPE 
 
This review covers the papers published till September 2009 on capillary electromigration 
techniques coupled with mass spectrometry for enantiomeric analysis of chiral compounds in 
different matrices. The separation techniques reviewed include capillary zone electrophoresis 
(CZE), micellar electrokinetic chromatography (MEKC) and capillary electrochromatography 
(CEC) on-line coupled to mass spectrometry (MS). This review is divided in three main parts, 
the first one focuses on the use of chiral CZE-MS, by far the approach most frequently used 
when combining chiral capillary electromigration analysis and MS. The second and third 
parts are devoted to the chiral applications of MEKC-MS and CEC-MS, respectively. Useful 
data on analytes, sample matrices, BGEs (or types of column used in CEC), instruments and 
interfaces are provided in tables to make easier to the reader the search for a specific 
application. The review ends with some concluding remarks and future outlooks on the 
expected developments and applications of these hyphenated methodologies in chiral 
analysis. 
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3. CHIRAL CAPILLARY ZONE ELECTROPHORESIS-MASS SPECTROMETRY 
(CHIRAL-CZE-MS).  
 
The most often used approach for chiral separations by CE-MS is direct enantioseparation by 
capillary zone electrophoresis-mass spectrometry (CZE-MS) adding to the BGE chiral 
selectors that involve transient non-covalent complexes formed in dynamic equilibrium. This 
direct chiral CE mode is also called chiral capillary electrokinetic chromatography (cEKC) 
and can also include the use of chiral micelles that will be revised in section 4. The main 
advantage of chiral analysis by CE is the flexibility on the use of a great variety of chiral 
selectors at low concentrations, reducing in this way the cost of the method. However, the 
main difficulty of the direct chiral approach by CZE-MS is the contamination of the ion 
source, since chiral selectors are usually non-volatile compounds. Among chiral selectors, 
cyclodextrins (CDs) have been demonstrated to be useful compounds for achieving good 
chiral resolution of a large variety of chiral molecules, mostly because their good solubility in 
water and the variety of cyclodextrins commercially available [26-28]. CDs are largely the 
most used compounds among chiral selectors in CE applications due to their particular 
physico-chemical properties and their great enantiorecognition capability. Moreover, CDs can 
be obtained with many different properties by modifying the hydroxyl groups of the CD 
structure. However, other chiral selectors are used for chiral separations in CE, such as chiral 
micelles, crown ethers, macrocyclic antibiotics, peptides, etc. In Table 2, an overview of the 
main chiral CZE-MS applications published till September 2009 is presented [32-63]. The 
majority of the CZE-MS works published until now describe applications in drug 
development and drug quality control, pharmacokinetic and pharmacodynamic studies. For 
instance, Lu and Cole [34] studied the suppression of MS analyte signal caused by the 
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introduction of CDs into the ion source and the dependence of analyte signal intensity and CD 
concentration. They obtained good chiral separations with acceptable sensitivities of 
terbutaline and ketamine using 5 and 15 mM heptakis(2,6-di-O-methyl)-β-cyclodextrin 
(DMBCD), respectively, and of propanolol with 20 mM of hydroxypropyl- -CD (HPBCD), 
in acidic volatile buffers and using no special approach to avoid the entrance of CDs in the 
ion source. The massive entrance of cyclodextrins into the ion source can be reduced using 
acidic electrolytes. Thus, Lio et al. [35] used 1 M formic acid at pH 2.2 to minimize 
electroosmotic flow inside the capillary. A combination of two different CDs, namely, 3 mM 
of -CD and 10 mM DMBCD was used in that work to improve the enantiomeric resolution 
of amphetamine, methamphetamine, dimethylamphetamine and p-hydroxymethamphetamine. 
The chiral CZE-MS method was applied to the analysis of these compounds in urine from 
addicts preceded by a solid-phase extraction (SPE) step to remove ammonia [35]. NACE-MS 
coupling using keptakis(2,6-diacetyl-6-sulfato)-β-cyclodextrin (DASBCD) as chiral selector 
in an acidic methanolic BGE, has been demonstrated to be useful for the quantitative 
determination of low levels of the enantiomers of the basic drug salbutamol in human urine 
previously submitted to a SPE procedure. The obtained LOQ were 20 ng/mL for both R and S 
salbutamol enantiomers [36]. 
 
The analysis of chiral compounds in foods and beverages is a very useful tool to asses their 
quality, corroborate their authenticity or detect microbiological contaminations. Moreover, 
determination of specific enantiomers or enantiomer ratios can provide valuable information 
about adulterations, control of fermentation processes and products, study of the effect of 
storage time, monitoring of age, etc. Among the food constituents, amino acids represent a 
very important group of chiral compounds. The potential of enantioseparation by CZE-MS of 
seven chiral amino acids and one achiral amino acid to detect adulterations in orange juices 
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was demonstrated [37]. A polymer coating of the inner capillary wall was used in this case to 
reduce the EOF and minimize in this way the entrance of the neutral -CD into the ion source 
[37]. In a recent paper, the non-protein chiral amino acid ornithine was determined by CZE-
MS in beers submitted to different fermentation processes. By operating the instrument in 
tandem mode (MS/MS), a significant increase in the signal was achieved, obtaining LOD of 
2.5·10
-9
 M, two orders of magnitude lower than the LOD obtained with UV detection [38]. 
The use of modified cyclodextrins was investigated for the separation of five chiral amino 
acids in vinegars and soybeans by CZE-MS (Figure 1). The new synthesised 3-monodeoxy-3-
monoamino- -cyclodextrin could bring additional ionic interactions due to its positive charge, 
increasing in this way the selector-analyte complex formation, and allowing in this way the 
use of low concentration of chiral selectors for their use in the CZE-MS coupling [39]. 
Analysis of chiral amino acids is also important in clinical studies and neuroclinical 
applications. Moini et al. [40] demonstrated that the chiral crown ether (+)-(18-crown-6)-
2,3,11,12-tetracarboxylic acid (18C6TCA) can act as an excellent background electrolyte 
acting also as a complexation chiral agent for the separation of 11 D/L enantiomers of amino 
acids and 2 small neurotransmitters by CZE-MS. Amino compounds were monitored with 
high sensitivity by MS as AA/18C6TCA complexes, reaching nM concentration detection 
limits. 
 
In order to minimize or avoid the contamination of the ESI-MS with the chiral selector, and 
improve therefore the sensitivity and the stability of the MS signal, different approaches and 
strategies have been employed in CZE-MS.  
 
3.1 Chiral selector counter migration. 
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To avoid in a simple way the entrance of the non-volatile chiral selectors into the ion source 
counter migration of charged chiral selectors can be used. Charged chiral selectors are of 
special importance since additional electrostatic interactions with oppositely charged 
enantiomers can contribute in the chiral recognition. Moreover, they can act as “carrier” for 
analytes, as it was first noticed by Terabe [64], making possible the chiral separation of 
neutral enantiomers. Apart of the higher solubility and improved chiral recognition of many 
charged CDs compared with neutral ones, one of the most important advantages of charged 
cyclodextrins derivatives is that they can be used in the counter-current mobility in CZE-MS. 
In these cases, the effective mobility of the charged chiral selector is towards the capillary 
inlet in order to avoid the contamination of the ion source of the MS with the chiral selector. 
However, the use of these charged chiral selectors brings about an increasing of the electrical 
conductivity of the BGE while they can adsorb onto the capillary wall reducing separation 
efficiency and resolution. Readers interested on this topic can take resort to the very 
interesting review recently published by Chankvetadze on the use of charged chiral selectors 
in CE [29]. 
 
The positively charged 2-hydroxypropyltrimethylammonium- -CD (TMABCD) [41] and 6-
monodeoxy-6-mono(3-hydroxy)propylamino- -CD (PABCD) [45], have been used in the 
counter-current mobility approach for the separation of tropic acid and five acidic drugs 
(ibuprofen, fenoprofen, flurbiprofen, ketoprofen and indoprofen), respectively. The use of 
coated capillaries was necessary in both cases in order to avoid the adsorption of the CDs into 
the inner capillary wall and the subsequent generation of anodic electroosmotic flow. 
 
Also negatively charged cyclodextrins derivatives have been used in CZE-MS trying to 
reduce the ion source contamination problem. Schulte et al. [41] reported the chiral separation 
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of mianserine, dimimethidene and chlorpheniramine chiral drugs using 0.2 mg/mL of 
carboxymethyl- -CD (CMBCD) in an ammonium acetate buffer at pH 3.5. Although higher 
concentration of CDs (3 mg/mL CMBCD) was needed for the separation of etilefrine 
enantiomers, migration of the CDs towards the anode avoided the negative effects of the 
presence of chiral selector in the ion source [41]. The same counter migration principle using 
highly sulfonated- -CD (HSBCD) was used to determine the potential chiral interconversion 
of a novel chiral drug in plasma samples [42]. The anionic heptakis(2,3-di-O-methyl-6-O-
sulfo)- -CD (DMSBCD) was used in a non-aqueous buffer for the chiral separation of 
mebeverine and five related compounds of pharmaceutical importance (Figure 2). Some ionic 
suppression was observed in this case from the sodium counter ion of the anionic CD that 
migrated towards the MS. Nevertheless, the LODs were in the sub-µg/mL range [44]. 
 
Since macrocyclic antibiotics, contain ionizable functional groups, the counter-current 
mobility principle can also be applied to prevent their entrance into the ion source. Using this 
approach, vancomycin was used for the enantioseparation of racemic non-steroidal anti-
inflammatory drugs, as well as two metabolites of the non-steroidal anti-inflammatory drug 
etodolac in human urine [46]. 
 
3.2 Partial filling technique. 
 
The partial filling technique (PFT) proposed by Hjerten and co-workers [65] to keep the UV-
absorbing chiral selectors away from the detection window has been proved to be very useful 
to prevent entering non-volatile chiral selectors into the MS. Several works have been 
published regarding the use of neutral chiral selectors and applying the PFT with percentages 
of the capillary filled from 50 to 90% [47-55]. Most of the works reported comprise 
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pharmaceutical and clinical research including enantioselective metabolism, bioavailability, 
and elimination of chiral drugs. One of the first CZE-MS methods using PFT employed 
methyl- -cyclodextrins (MBCD) for chiral separation of drugs [47]. Since then, several 
research groups used this approach to avoid the entrance of the neutral cyclodextrins in the 
ion source [47-55]. HPBCD was used in CZE-MS for the chiral separation of a chiral 
adrenoreceptor antagonist, filling 80% of an uncoated capillary [50]. When decreasing the 
percentage of filled capillary lower resolution between enantiomers was obtained but higher 
peak efficiencies and signal/noise ratios were observed. Using MS detection sensitivity was 
enhanced by a factor of 30 compared to CZE-UV, reaching LOD of each adrenoreceptor 
antagonist enantiomer of 5 ng/mL [50]. PFT using DMBCD as chiral selector was also very 
useful for the determination by CZE-MS of enantiomers of clenbuterol and salbutamol in 
plasma, reaching LOD values of 0.22 µg/mL [52]. A NACE-MS method filling 55% of the 
capillary with the chiral selector (2)-2,3:4,6-di-O-isopropylidene-2-keto-L-gulonic acid 
(DIKGA) was proposed to separate pronethalol enantiomers [54]. In a recent work [55], the 
separation of 5 chiral dipeptides was accomplished by filling 53% of the capillary with the 
chiral crown ether 18C6TCA in a low pH buffer. Despite of the low percentage of the 
capillary filled a good separation of the chiral peptides was obtained. 
 
Many chiral CZE-MS works published so far combine CS counter migration and PFT. Thus, 
positively charged chiral selectors were combined with polyacrylamide-coated capillaries to 
suppress EOF and avoid adsorption of the chiral selectors onto the inner capillary wall. The 
separation of tropic acid was studied by Tanaka et al. [48] using 70% of the capillary filled 
with quaternary ammonium -CD (QABCD) as chiral selector. In the same work, several 
methods were also described using the chiral selector avidin, which migrated towards the 
cathode (injection end) at pH 6. Using a 70% filled capillary with the chiral selector good 
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stereoselective resolution of acidic pharmaceuticals was obtained, including arylpropionic 
acids ibuprofen, ketoprofen, and the anticoagulant warfarin. 
 
The negatively charged sulfobutyl ether β-CD (SBEBCD) was used to obtain baseline 
resolution of tramadol and 5 of its phase I metabolites. A 90% filled polyvinylalcohol-coated 
capillary with the CS was used for the determination of these compounds in plasma collected 
2 h after the administration of 100 mg of tramadol hydrochloride to a healthy volunteer [56]. 
The chiral separation of the antidepressant drug venlafaxine and 3 of its phase I metabolites 
was studied by filling 90% of a PVA-coated capillary wit 40 mM ammonium acetate buffer at 
pH 4 containing 2 mg/mL of CMBCD. All compounds excepting one of the three metabolites 
were well resolved [53]. Sulfated -CD (SBCD) showed to be more effective for the counter 
current PFT than the negatively charged SBEBCD and CMBCD for the enantioseparation of 
the three anaesthetic drugs ketamine, prilocaine and mepivacaine [57]. 
 
When no capillary coating is used, BGE pHs lower than 2.5 were used in order to avoid the 
entrance of the CDs into the ion source by the effect of the EOF. Moreover, there is a trend on 
the use of lower percentage of filled capillary with the CS when no capillary coating is used 
[58-63]. For example, Schappler et al. [60] developed a CE-MS method to analyze plasma 
samples containing five amphetamine derivatives and the two drugs tramadol and methadone. 
50% of the capillary was filled with 0.15% highly sulfated -CD (HSGCD) in a 20 mM 
ammonium formate buffer at pH 2.5, obtaining a LOD of 0.5 ppb for each enantiomer (Figure 
3). In a recent paper, the determination of D and L carnitine in different infant formulas is 
described [63]. Succinyl- -cyclodextrin (SuccGCD) was used filling 50% of the capillary with 
this CS in a 0.5 M ammonium formate BGE at pH 2.5. In order to improve sensitivity and 
selectivity of the CZE-MS method, MS/MS experiments with an ion trap analyzer were 
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carried out. Thus, a 100-fold sensitivity enhancement with respect to UV detection was 
obtained, achieving LOD of 100 ng/g for D-carnitine. 
 
3.3 Other approaches. 
 
Although in a much less extent, indirect chiral separation has also been used in CZE-MS. 
Indirect chiral separation implies the formation, using pure chiral reagents, of covalent 
diastereomers that inherently show different electrophoretic mobilities in achiral BGEs. The 
main drawbacks of this approach are that a high enantiomeric purity of the derivatization 
reagent is needed while the derivatization procedure is usually a time-consuming step. Thus, 
Day et al. [66] described the chiral derivatization of D/L-selenomethionine with 1-fluoro-2,4-
dinitrophenyl-5-L-alanine amide (Marfey’s reagent). The obtained diastereomers were then 
analyzed by CZE-ICP MS using a 30 mM ammonium phosphate buffer at pH 3.3 and 
working in reverse CE polarity. The method allowed the analysis of the derivatized 
selenomethionine diastereoisomers in spiked selenized yeasts samples, together with small 
peptides containing selenium present in this kind of samples. 
 
Other strategies have also been developed to avoid the entrance of the chiral selector in the 
ion source. As stated above, anionic CS are used in normal polarity CE mode to avoid the 
contamination of the MS with these non-volatile compounds, however, the simultaneous 
analysis of nine amphetamines, reported by Iwata et al. [67] was only allowed when the 
anionic HSGCD was used in reversed polarity CE. In these conditions the amphetamine 
(positively charged) and HSGCD (negatively charged) complexes migrated towards the ion 
source. It was found that the amphetamines were dissociated from the HSGCD in the ion 
source. Working in the positive ESI mode the positively charged amphetamines entered into 
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the MS analyzer while dissociated or HSGCD excess were not introduced into the MS 
reducing its deleterious influence. On the other hand, due to the counter migration of the 
analytes and the CS, long analysis times were required (about 50 min). 
 
Non-continuous flow CZE-MS was applied for the separation of omeprazole enantiomers 
using 5 mM heptakis-(6-sulfo)-β-CD in a 10 mM ammonium acetate buffer at pH 5.8 [68]. To 
minimize the contamination of the MS with the CDs the CE separation was performed with 
the ESI and sheath flow switched off during the CE separation. After 30 min, the ESI voltage 
and sheath flow were applied allowing the separated omeprazole enantiomers to enter into the 
MS analyzer. 
 
4. CHIRAL MICELLAR ELECTROKINETIC CHROMATOGRAPHY-MASS 
SPECTROMETRY (CHIRAL-MEKC-MS). 
 
Although novel MEKC-based methodologies have recently been proposed for chiral analysis, 
the combination of MEKC methods with MS detection has still some important problems. 
Thus, one of the main limitations of this coupling is the lack of compatibility of the most 
widely used surfactants in MEKC separation with mass spectrometers. Generally, surfactant 
monomers suppress the ionization of the analyte in the spray chamber, which in turn, provides 
an increased chemical noise in the electrospray reducing sensitivity of the whole MEKC-MS 
analysis. In last years, the use of high-molecular-mass micelle polymers (also referred to as 
micelle polymers or molecular micelles) as pseudostationary phase has demonstrated to be an 
interesting alternative to more conventional micelles for the analysis of enantiomers with 
MEKC-MS (the main works published so far on chiral-MEKC-MS are summarized in Table 3 
[69-76]). These micellar systems are synthesized from surfactants having a polymerizable 
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group and the main advantages of these structures in MEKC-MS include: (i) a simplified and 
enhanced binding between the analyte and the micelle; (ii) they can be used at any polymeric 
surfactant concentration due to zero critical micelle concentration, and therefore, better S/N 
ratio are usually obtained in MEKC-ESI-MS analyses; (iii) molecular micelles are stable in 
the presence of organic solvents due to the covalent bond formed between monomers; (iv) the 
better stability of micelles prevents dissociation of monomers during electrospray process and 
also, micelles produce less background interference due to their high molecular weight; (v) 
due to their lower surface activity, molecular micelles provide less ion suppression and more 
stable electrospray.  
  
Chiral separations with MEKC-MS were first reported by Shamsi [69] who showed the 
feasibility of the molecular micelles with polysodium N-undecanoyl-L-valinate (poly-L-SUV) 
as pseudostationary phase for the separation of binaphthol (BOH) enantiomers. Electrospray 
parameters (voltage, nebulizing gas pressure, drying gas temperature, drying gas flow rate, 
sheath liquid flow rate) affecting the sensitivity were first examined and after that, other 
separation conditions (pH, micelle polymer concentration, and volatile background electrolyte 
concentration) were evaluated to obtain the best possible resolution of enantiomers without 
sacrificing sensitivity. The micelle polymer concentration was found to have a significant 
impact on chiral resolution and S/N ratio of BOH, providing good results at concentrations 
around 0.2% (w/v) poly-L-SUV. 
 
Later, the versatility of new alkenoxy amino acid molecular micelle, i.e., polysodium N-
undecenoxycarbonyl-L-leucinate (poly-L-SUCL) as chiral selector in MEKC-MS was 
investigated for the simultaneous enantioseparation of eight structurally similar β-blockers 
[70]. Under optimum sheath liquid and spray chamber conditions, the effect of MEKC 
 
 
 
17 
separation parameters was studied to find a good compromise between enantioseparation and 
sensitivity. Separation parameters as pH, volatile BGE concentration, polymeric surfactant 
concentration and, nebulizing gas pressure demonstrated to play an important role in the 
chiral resolution, S/N ratio of the analytes and analysis time. In general, a decreased chiral 
resolution was observed at basic pH values, lower BGE concentrations and nebulizing gas 
pressures, whereas the variation on chiral resolution when poly-L-SUCL concentration 
demonstrated to be analyte dependent. More precisely, chiral resolution values of hydrophilic 
β-blockers were increased while those of hydrophobic β-blockers were decreased at higher 
surfactant concentrations. Also, a comparison of monomeric and polymeric L-SUCL under 
optimum experimental conditions demonstrated that, generally, polymer micelles showed 
better performance than unpolymerized micelles at the same monomer concentration. Authors 
explained these results as a consequence of the tendency of unpolymerized micelles to break 
down once they are into the ESI chamber, thus resulting in unstable electrospray, which in 
turn, increases background noise of the mass spectrometer.  
 
Next, Shamsi and co-workers extended their experiments to study the applicability of six 
amino acid-based polymeric surfactants to the simultaneous enantioseparation of three chiral 
compounds, i.e., two benzodiazepines and one benzoxazocine with MEKC-MS [71]. The 
amino acid-based polymeric surfactants included three carbamate-type polymers [poly-L-
SUV, polysodium N-undecanoyl-L-leucinate (poly-L-SUL), and polysodium N- undecenoyl-
L,L-leucyl-valinate (poly-L,L-SULV)], and three amide-type polymers [poly-L-SUCL, 
polysodium N-undecenoxycarbonyl-L-valinate (poly-L-SUCV), and polysodium N-
undecenoxycarbonyl-L,L-leucyl-valinate (poly-L,L-SUCLV)]. MEKC-MS separations with 
the six different polymer micelles of a mixture containing three pairs of stereoisomers of 
chiral drugs provided different selectivity. The carbamate-type polymers showed slightly 
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longer retention, but good chiral resolution for the two benzodiazepines, whereas no chiral 
separation for the cationic and the most retained benzoxazocine drug. On the other side, 
dipeptide polymeric surfactants (poly-L,L-SUCLV and poly-L,L-SULV) showed higher S/N 
ratios than single-amino acid polymeric surfactants in most cases. In this study, the addition 
of methanol and 2-propanol as organic modifiers to the running buffer increased the migration 
times of all three solutes in a linear way, whereas the addition of ACN showed a maximum 
for the migration time of the solutes at 10% v/v ACN, and then a further increase of ACN 
content resulted in shorter migration times. Authors suggested that the differential effect of 
ACN in this separation system might be due to a decreased association of solutes to polymeric 
surfactant at higher ACN concentrations. Under optimum conditions, the developed MEKC-
MS method provided LODs ~1.8 µg/mL for the analytes that were nearly three to four-fold 
better than those obtained with chiral MEKC-UV.  
 
In a separate study, the same group reported on the application of the poly-L,L-SULV 
polymeric surfactant for the separation and determination of warfarin enantiomers in human 
plasma with MEKC-MS [72]. Using poly-L,L-SULV, a decreased chiral resolution was 
observed when the pH of the running buffer was increased from 5.5 to 8.0. Authors explained 
this loss of resolution by the enhancement of electrostatic repulsive interactions between the 
polymeric micelle due to the higher effective charge of the analyte and surfactant at less 
acidic pH values. On the other side, as buffer pH increases, the S/N ratio increases possibly 
due to a decrease of migration times and a better ionization of analytes under negative ion 
mode at the interface. After systematic optimization, the developed MEKC-MS method was 
applied to the analysis of warfarin enantiomers in human plasma samples spiked with 
different amounts of enantiomers. The sensitivity obtained with the chiral MEKC-MS method 
(LOD 0.1 µg warfarin enantiomers/mL) was comparatively better to the one obtained with 
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chiral MEKC-UV (LOD 5 µg/mL) demonstrating the good possibilities of MEKC-MS for the 
monitoring of this anticoagulant drug in plasma samples. 
 
Further studies by the same group with polysodium N-undecenoxycarbonyl-L-amino acid 
sulfates (poly-L-SUCAAS) demonstrated the good performance and versatility of these 
polymeric micelles for chiral MEKC-UV analysis of ten structurally different 
phenylethylamines (PEAs) under acidic conditions (pH 2.0-3.0) [73]. To investigate the 
applicability of poly-L-SUCAAS as a pseudostationary phase to MEKC-MS under acidic 
conditions, Rizvi et al. used polysodium N-undecenoxycarbonyl-L-leucine sulfate (poly-L-
SUCLS) for the enantioseparation of pseudoepinephrine in human urine samples. Severe 
arching problems were encountered possibly due to the formation of very strong ion pairs 
with negatively charged micelles and the positively charged analytes at low pH. The addition 
of 1% valeric acid (v/v) to the sheath liquid improved the sensitivity as this ion-pairing 
reagent competes for the ion pair formation with the charged compounds. After optimization 
of sheath liquid and MS spray chamber parameters, the reported LODs were almost 16 times 
lower (LOD 325 ng/mL) for the analyses performed at pH 2 than at pH 8.0 (LOD 5.2 µg/ml).  
 
Last developments in this field have been focused on the application of multivariate 
approaches for the study and optimization of the most relevant parameters affecting the chiral 
separation in MEKC-MS with polymeric micelles. Thus, Hou et al. [74] developed a MEKC 
separation method with MS detection and the use of poly-L-SUCL surfactant for the 
simultaneous separation of four pairs of ephedrine stereoisomers. In this study, the parameters 
affecting MEKC separation of the analytes were first investigated and then, a central 
composite design was carried out in order to evaluate independently the effects and 
interactions between the spray chamber parameters and between sheath liquid conditions. In 
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the first method development stage, MEKC experiments with different organic modifiers in 
the BGE revealed similar results to those previously reported for the chiral MEKC separation 
of benzodiazepines and benzoxazocine [71]. Using the optimized MEKC conditions, the 
response surface 3-D contour plots obtained from the central composite design experiments 
indicated the optimum conditions for the best sensitivity. Next, the developed method was 
applied to the analysis of ten enantiomers of ephedrine and related compounds in standard 
reference materials with different enantiomeric composition (Figure 4) [75]. In this study, the 
comparison between MEKC-MS and MEKC-UV indicated that MS detection provides better 
sensitivity, but a slightly lower dynamic range for quantitation. Authors reported %RSDs 
values lower than 0.77% and 1.80% for migration time within the same day and different 
days, respectively, and the overall limits of detection ranged from 0.00037 to 12.49 mg/g. 
 
More recently, central composite design has also been applied to evaluate the importance of 
selected MEKC-MS parameters for the simultaneous chiral separation of BOH and 1,1’-
binaphthyl-2,2’diylhydrogen phosphate (BNP) enantiomers [76]. In this case, a first 
experimental design for MEKC optimization, based on six factors and three-levels, was 
proposed. The analysis of data obtained from 86 MEKC-MS runs suggested that nebulizer 
pressure had the most significant influence on the chiral resolution. Voltage and polymeric 
surfactant concentration had more pronounced effect on the chiral resolution of BOH and (±) 
BNP, respectively, whereas ammonium acetate concentration and temperature did not affect 
the chiral separation of the analytes significantly. Same methodology was used to evaluate the 
effect of the sheath liquid and spray chamber parameters on S/N ratio. Finally, the optimum 
conditions, a combination of the optimal from the three parts of the study (MEKC, sheath 
liquid and spray chamber optimization), were used to run 20 replicate runs. The obtained 
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enantiomeric resolutions for BOH and BNP differed 4% and 26%, respectively, from the 
predicted values, whereas the migration times were 3% higher than the predicted value.  
 
5. CHIRAL CAPILLARY ELECTROCHROMATOGRAPHY-MASS 
SPECTROMETRY (CHIRAL-CEC-MS). 
 
The application of CEC-MS to the analysis of chiral compounds has been explored in 
different ways by several research groups as can be seen in Table 4 [77-83]. Thus, Schurig 
and Mayer [77] developed a CEC-MS method based on an open-tubular capillary internally 
coated with polysiloxane-bonded permethyl-β-cyclodextrin as chiral stationary phase for the 
enantioseparation of the sedative-hypnotic drug hexobarbital in human urine. To avoid co-
elution of urine components with the same mass, a liquid-liquid extraction step of the sample 
was included prior to its injection into the capillary column. In this case, the detection system 
consisted of an electrospray interface coupled to a quadrupole mass spectrometer. Thus, 
hexobarbital enantiomers were detected within 2 minutes at concentrations below the 
therapeutic levels (20-50 ng/mL). 
 
 Von Brocke et al. [78] reported on the on-line coupling of pressure supported CEC using 
packed capillaries with ESI-MS and coordination ion spray (CIS)-MS for the chiral analysis 
of barbiturates and chlorinated alkyl phenoxypropanoate enantiomers. To achieve their 
separation, in-lab prepared capillaries (100 µm ID), packed with permethylated β-
cyclodextrin-modified silica (5 µm, 300 Å) were used. The use of a coordination ion solution 
(sheath flow) is one of the main features of the CEC-CIS-MS coupling because this ensures 
stable spray conditions and acts as complexing reagent to provide ionization of analytes. 
Hence, many coordination compounds are available for introducing a charge to the analytes 
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providing different selectivity. In their study, authors investigated the separation and detection 
of hexobarbital and mephobarbital with CEC-CIS-MS using silver(I), cobalt(II) and 
copper(II) salts, whereas the results demonstrated that the use of lithium(I) salt was 
impracticable. On the other hand, chlorinated alkyl prenoxypropanoates showed high affinity 
to lithium salts, providing better sensitivity to the detection of these enantiomers. 
 
Several works have been published describing the use of capillary packed with different chiral 
stationary phases for the analysis of enantiomers. Zheng and Shamsi [79], for example, 
investigated the effect of different column fabrication on the CEC-MS analysis of warfarin 
and coumachlor enantiomers. Using a 0.5 µm (3R,4S)-Whelk-O1 chiral stationary phase, the 
results suggested that externally tapered capillary columns provided better reproducibility 
(RSDs ~ 5%)  than untapered columns (RSDs ~ 31%) for the migration time. This 
observation is possibly due to the formation of bubbles in the open segment of the untapered 
columns, which has been associated with the retaining frit between the packed and open 
segments of the capillary. In contrast, this problem was avoided in tapered columns because 
the end acts as a back-pressure resistor and suppressed the bubble formation. Also, the 
influence of acetonitrile content, buffer pH, and ionic strength on CEC separation in tapered 
columns was explored. Then, other parameters associated with MS detection were 
investigated to maximize the sensitivity of the method. Authors proved the applicability of the 
optimized CEC-MS method for the detection or warfarin enantiomers by analyzing spiked 
human plasma samples, previously treated with C18 solid-phase extraction columns. In 
subsequent studies, the same group improved the fabrication of packed capillaries by 
developing a novel type of more robust columns, suitable for ESI-MS coupling [80]. Using a 
simplified fabrication procedure, it was possible to obtain internally tapered columns with an 
opening of 7-10 m i.d., which were subsequently packed with vancomycin chiral stationary 
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phase. The performance of the new columns was tested under both reversed-phase and polar 
organic phase modes of CEC-MS. A comparison between externally and internally tapered 
columns demonstrated that the latter columns provided better electrospray stability and 
reproducibility. The longer lifetime of the internally tapered column, especially under polar 
organic conditions, was also beneficial for the analysis of eight β-blockers enantiomers, 
suggesting much better ruggedness, as compared to externally tapered columns. In addition, 
authors demonstrated a batch-to-batch column reproducibility lower than 4.1% (RSD 
obtained with four columns and 20 injections of eight β-blockers on each column). In a 
further study, the effect of different parameters related with the mobile phase, stationary 
phase, sheath liquid, and ESI spray chamber were investigated in order to obtain high 
resolution and sensitivity of eight β-blockers with CEC-MS and internally tapered columns 
[81]. The use of long packed columns (90 cm) enabled larger volume injections without 
overloading, at the expense of longer analysis times. In general, an increase in mobile phase 
ionic strength enabled much robust current and EOF, and sample stacking, which resulted in 
enhanced sensitivity. Thus, a mobile phase based on methanol-ACN (70:30, v/v) containing 
1.6% (v/v) acetic acid and 0.2% (v/v) triethylamine provided a good compromise between 
resolution and analysis time. The quantitative capabilities of the method were also 
demonstrated over a wide concentration range (3-600 M), and more interestingly, the 
developed CEC-MS method allowed the detection of traces (0.1% enantiomeric impurity) in 
non-racemic mixtures. In a separate report, preliminary sequential optimization of CEC-MS 
parameters, including mobile phase composition, column temperature and electric field 
strength was carried out to obtain the separation of eight β-blockers, i.e., four stereoisomers of 
labetalol and four steroisomers of nadolol [82]. Then, a second optimization procedure was 
established in order to reduce the analysis time and improve the sensitivity. To achieve this, a 
first multivariate design was used, considering the three most important factors (organic 
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composition, percent of acetic acid and percent of triethylamine) on the analysis time. To 
increase the S/N ratio, two more multivariate studies were subsequently run, one for sheath 
liquid parameters optimization (addition of ammonium acetate and acetic acid) and the second 
one for the spray chamber parameters optimization (nebulizer pressure, drying gas flow rate, 
and temperature). The multivariate optimization led for a reduction of 15 min in the overall 
analysis time (from 75 to 60 min) of the eight enantiomers and also, average S/N ratios 
greater than 1000 were obtained. 
 
Recently, Zheng et al. [83] have investigated the capabilities of sulfated and sulfonated 
polysaccharide as chiral stationary phases for CEC-MS analysis of a broad range of 
compounds. In their work, authors presented new alternative cellulose tris(3,5-
dimethylphenylcarbamate)-based stationary phases (6-SO4-CDMPC and CDMPC-SO3) with 
good potential for faster CEC enantiomeric separations under normal phase conditions. The 
results demonstrated a 50% reduction in the analysis time of several enantiomers when using 
6-SO4-CDMPC and CDMPC-SO3, which suggested a good correlation between the 
magnitude of EOF and the content of ionizable groups on the chiral stationary phases. 
However, a loss of resolution was observed in the analyses performed with 6-SO4-CDMPC 
possibly due to the different content of ionizable groups and cellulose structure compared to 
that in CDMPC-SO3. Experiments with the latter negatively charged polysaccharide and 
mobile phases with different ionic strength (2-8 mM ammonium acetate) suggested the 
existence of cationic-exchange mechanisms on the separation of pindolol enantiomers with 
CDMPC-SO3. Authors also explored the effect on the enantioseparation of silica particle pore 
size chiral stationary phase loading, demonstrating good resolving power for a wide range of 
acidic, neutral and basic compounds with 20% stationary phase loadings (5 m particles, 
1000 Å). The organic composition of sheath liquid demonstrated to have a strong impact in 
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the S/N ratio of normal phase CEC-MS analyses. Under normal phase conditions, the 
presence of IPA in the sheath liquid enhanced the detection sensitivity, probably due to a 
better miscibility of hexane with 2-propanol than with methanol. Nevertheless, authors 
indicated that normal phase mode generally provided the lowest sensitivity of warfarin and 
Troger’s base enantiomers because hexane produces ESI-MS signal suppression when it is 
used in the mobile phase (Figure 5). 
 
 
6. CONCLUDING REMARKS AND FUTURE OUTLOOKS. 
 
Compared with the chiral applications of GC-MS or HPLC-MS, CE-MS can be considered as a 
novice also for chiral analysis. In this regard, the high resolving power, rapid method 
development, easy sample preparation and low operation expense (allowing the use of 
sophisticated and/or very expensive chiral selectors) of CE have made of this technique a very 
interesting alternative for chiral analysis. However, the combination of CE and MS still needs to 
demonstrate its huge potential for chiral analysis trying to overcome its main limitations linked 
to the robustness of the CE-MS interface and the low compatibility between the chiral selector 
and the ionization source. These limitations are still key issues to be solved and they clearly need 
to be worked out before both CE-MS and its application for chiral analysis can be considered 
routine approaches.  
 
Some other new and interesting developments and uses within the chiral-CE and CE-MS 
domains will foreseeably be important application areas for chiral-CE-MS in the non-distant 
future. These developments include chip-based enantioselective separations [84], synthesis of 
new chiral phases (based e.g., on molecularly imprinted polymeric monoliths [85] or organogels 
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[86]), high-throughput chiral analysis by capillary array electrophoresis [87], chiral-CE-MS 
applications in metabolomics [88,89] or applications of chiral-CE-MS in the new Foodomics 
field [90]. The development of these new approaches will make broader the applications area of 
this technique while allowing to study from a different perspective new fields of research.   
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Table 1: Reviews published in the last 10 years (1999-2009) on chiral capillary 
electromigration methods including information on chiral-capillay electromigration-MS 
analysis. 
   
Subject 
Publication 
Year 
Reference 
   
   
Enantioseparations using capillary electromigration techniques 1999 [5] 
Polymeric surfactants in electrokinetic chromatography 1999 [6] 
Enantioresolution of pharmaceutical compounds by capillary electrophoresis 1999 [7] 
Enantioselective determination by capillary electrophoresis with cyclodextrins 2000 [8] 
Enantioseparations using CE techniques in nonaqueous buffers 2000 [9] 
Enantiomer separation of drugs by capillary electromigration techniques 2000 [10] 
Enantioseparations by capillary electrochromatography 2001 [11] 
Enantioseparation of chiral drugs by electromigration techniques 2001 [12] 
Enantioseparations in capillary electromigration techniques 2001 [13] 
Chiral CE-MS: modes and applications 2002 [14] 
Enantiomer migration order in chiral capillary electrophoresis 2002 [15] 
Chiral electromigration methods in food analysis 2003 [1] 
Enantioresolutions by capillary electrophoresis using glycopeptide antibiotics 2004 [16] 
Capillary electrochromatography coupled to mass spectrometry 2004 [17] 
CE-MS for small achiral and chiral solutes 2004 [18] 
Enantioseparation in CEC using polysaccharide-type chiral stationary phases. 2004 [19] 
Extraction-separation techniques coupled to mass spectrometry 2005 [20] 
Chiral molecular recognition for the MS detection and analysis of enantiomers  2005 [21] 
Chiral analysis of pollutants and their metabolites by CE methods 2005 [22] 
Capillary electrophoresis with mass spectrometric detection 2006 [23] 
Chiral separation using capillary electromigration techniques 2007 [24] 
The story of 20 and a few more years of enantioseparations by CE 2007 [25] 
Cyclodextrins in capillary electrophoresis enantioseparations 2008 [26] 
The role of cyclodextrins in chiral capillary electrophoresis 2008 [27] 
Chiral separations by CE employing cyclodextrins. 2009 [28] 
Separation of enantiomers with charged chiral selectors in CE 2009 [29] 
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Table 2. Chiral-CZE-MS applications 
 
 
 Chiral Analyte Sample Capillary BGE and CE polarity PFT MS Ref. 
I. No CS counter migration, no partial filling technique 
 Terbutaline and ephedrine Urine Bare 
5 mM sodium phospahate  pH 2.5, 
5 mM DMBCD. +30 kV 
- 
ESI-QqQ 
(+) 
[32] 
 
Dichlorprop, fenoprop 
and mecoprop herbicides 
- Bare 
50 mM ammonium acetate buffer pH 4.6, 
20 mM TMBCD. - 27.5 kV 
- 
ESI-IT 
(-) 
[33] 
 Terbutaline and Ketamine - Bare 
5 mM ammonium acetate, 0.8 M acetic acid, 
80% (v/v) methanol, 5-15 mM DMBCD. +25 kV 
- 
ESI-Q 
(+) 
[34] 
 Propanolol - Bare 
5 mM ammonium acetate, 0.8 M acetic acid, 
80% (v/v) methanol, 20 mM HPBCD. +25 kV 
- 
ESI-Q 
(+) 
[34] 
 Methanfetamine and metabolites Urine Bare 
1 M formic acid pH 2.2, 3 mM -CD, 
10 mM DMBCD. + 30 kV 
- 
ESI-IT 
(+) 
[35] 
 Salbutamol Urine Bare 
10 mM ammonium formate, 15 mM DASBCD, 
in methanol. + 25 kV (+16 mbar) 
- 
ESI-IT 
(+) 
[36] 
 6 Amino acids Orange juice 
Polymer-
coated 
100mM ammonium acetate pH 6, 
5mM -CD. - 15 kV 
- 
ESI-IT 
(+) 
[37] 
 Ornithine Beer Bare 
50 mM ammonium carbonate pH 10, 
0.75 mM  -CD. + 25 kV 
- 
ESI-IT 
(+) 
[38] 
 5 Amino acids Vinegar, soybeans Bare 
50 mM ammonium hydrogen carbonate pH 8, 
0.5 mM charged-CD. + 30 kV 
- 
ESI-TOF 
(+) 
[39] 
 
11 amino acids 
and 2 neutrotransmitters 
Red blood cells Bare 
30 mM 18C6TCA. 
+ 30 kV 
- 
ESI-IT 
(+) 
[40] 
II.  CS counter migration 
 Tropic acid - 
PAA-
coated 
10 mM acetic acid-ammonium acetate pH 5, 
8 mg/mL TMABCD. -16 kV 
- 
ESI-IT 
(-) 
[41] 
 
Etilefrine, mianserine, 
dimimethidene and chlorpheniramine 
- Bare 
10 mM acetic acid-ammonium acetate pH 3.5, 
0.2-3 mg/mL CMBCD. + 20 kV 
- 
ESI-IT 
(+) 
[41] 
 1 Chiral drug Plasma Bare 
5 mM ammonium acetate pH 6, 1% acetic acid, 
25% methanol, 0.3% HSBCD. + 25 kV (+1 psi) 
- 
ESI-Q 
(+) 
[42] 
 Methanfetamine and metabolites Urine Bare 
1 M ammonium formate pH 2, 
1.5 mM DASBCD. + 30 kV 
- 
ESI-IT 
(+) 
[43] 
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Mebeverine and 5 related 
chiral compounds 
- Bare 
0.75 M formic acid, 30 mM potassium 
camphorsulfonate, 
30 mM HDMSBCD, in methanol. + 30 kV 
- 
ESI-IT 
(+) 
[44] 
 
Ibuprofen, fenoprofen, flurbiprofen, 
ketoprofen and indoprofen 
- 
PVA-
coated 
20 mM ammonium acetate, 20 mM PABCD, 
in methanol. -30 kV (+15 mbar) 
- 
ESI-IT 
(-) 
[45] 
 12 Arylpropionic acids Urine 
PAA-
coated 
50 mM ammonium acetate pH 4.8, 
5 mM vancomycin. - 20 kV 
- 
ESI-IT 
(-) 
[46] 
III.  No CS counter migration + Partial filling technique 
 Bupivacaine and ropivacaine - 
PAA-
coated 
30 mM acetic acid, 100 mg/mL MBCD. 
+ 30 kV 
80% 
ESI-QqQ 
(+) 
[47] 
 Camphorsulfonic acid - 
PAA-
coated 
40 mM ammonium formate pH 4, 
50 mM DMBCD. - 30 kV 
70% 
ESI-QqQ 
(-) 
[48] 
 
3 racemic compounds with 
a primary amino group 
- 
PAA-
coated 
40 mM ammonium formate pH4, 
2-5 mM 18C6TCA. + 25 kV 
70% 
ESI-QqQ 
(+) 
[49] 
 Adrenoreceptor antagonist - Bare 
50 mM ammonium formate pH 4, 
10 mM HPBCD. + 25 kV 
80% 
ESI-QqQ 
(+) 
[50] 
 R/S-Methadone - 
PVA-
coated 
20 mM ammonium acetate pH 4, 
18 mg/mL HPBCD. + 20 kV 
90% 
ESI-Q 
(+) 
[51] 
 Clenbuterol and salbutamol Plasma Bare 
10 mM ammonium acetate pH 2, 20% (v/v) 
methanol, 
40 mM DMBCD. + 30 kV (+10 mbar) 
66% 
ESI-QqQ 
(+) 
[52] 
 6 Amphetamines and derivatives - 
PVA-
coated 
40 mM ammonium acetate pH 3, 
24 mg/mL HPBCD. + 30 kV 
90% 
ESI-Q 
(+) 
[53] 
 Phonethalol - Bare 
20 mM ammonium acetate in methanol-2-propanol 
(75:25, v/v), 80 mM DIKGA. + 25 kV 
55% 
ESI-Q-
TOF 
(+) 
[54] 
 5 chiral dipeptides - Bare 
3 M acetic acid pH 2, 
5 mM 18C6TCA. + 20 kV 
53% 
ESI-Q 
(+) 
[55] 
IV.  CS counter migration + Partial filling technique 
 Tropic acid - 
PAA-
coated 
40 mM ammonium formate pH 5, 
5 mM QABCD. - 30 kV 
70% 
ESI-QqQ 
(-) 
[48] 
 Ibuprofen and ketopfrofen - 
PAA-
coated 
40 mM ammonium formate pH 6, 
10% (v/v) 2-propanol, 0.1 mM avidin. - 30 kV 
70% 
ESI-QqQ 
(-) 
[48] 
 Warfarin - 
PAA-
coated 
40 mM ammonium formate pH 6, 
10% (v/v) ethanol, 0.1 mM avidin. - 30 kV 
70% 
ESI-QqQ 
(-) 
[48] 
 Tramadol and metabolites Plasma 
PVA-
coated 
40 mM ammonium acetate pH 4, 
2.5 mg/mL SBEBCD. + 25 kV 
90% 
ESI-Q 
(+) 
[56] 
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 Methadone - 
PVA-
coated 
20 mM ammonium acetate pH 4, 
0.25 mg/mL CMBCD. + 20 kV 
70% 
ESI-Q 
(+) 
[51] 
 Methadone - 
PVA-
coated 
20 mM ammonium acetate pH 4, 
0.4 mg/mL SBEBCD. + 20 kV 
90% 
ESI-Q 
(+) 
[51] 
 Methadone and related metabolites Serum 
PVA-
coated 
40 mM ammonium acetate pH 4, 
1 mg/mL CMBCD. + 30 kV 
90% 
ESI-Q 
(+) 
[53] 
 Venlafaxine and related metabolites - 
PVA-
coated 
40 mM ammonium acetate pH 4, 
2 mg/mL CMBCD. + 30 kV 
90% 
ESI-Q 
(+) 
[53] 
 Atropine and Homatropine - 
PVA-
coated 
30 mM ammonium acetate pH 7, 
2 mg/mL SBCD. + 30 kV 
75% 
ESI-Q 
(+) 
[53] 
 
Ketamine, prilocaine 
and mepivacaine 
- 
PVA-
coated 
20 mM ammonium formate pH 3, 
2.5-10 mg/mL SBCD. + 30 kV 
90% 
ESI-Q 
(+) 
[57] 
 
Methadone, Tramadol, 
Venlafaxine, Fluoxetine 
- Bare 
30 mM ammonium formate pH 2.5, 
0.1-0.85% HSGCD. + 25 kV 
83% 
ESI-Q 
(+) 
[58] 
 
7 Amphetamines and 
related compounds 
Plasma Bare 
20 mM ammonium formate pH 2.5, 
0.15% HSGCD. + 30 kV 
60% 
ESI-Q 
(+) 
[59] 
 
Five amphetamine derivatives, 
tramadol and methadone 
Plasma Bare 
20 mM ammonium formate pH 2.5, 
0.15% HSGCD. +25 kV 
50% 
ESI-Q 
(+) 
[60] 
 Baclofen Formulation Bare 
0.25 M formic acid, 
1.75 mM SBEBCD. + 25 kV 
88% 
ESI-IT 
(+) 
[61] 
 Ecstasy and methadone Plasma Bare 
15 mM ammonium formate pH 2.5, 
0.08% HSGCD. + 30 kV 
70% 
ESI-Q 
(+) 
[62] 
 Carnitine Infant formula Bare 
0.5 M ammonium formate pH 2.5, 
10 mM SuccGCD. + 25 kV 
50% 
ESI-IT 
(+) 
[63] 
Abbreviations: 
CMBCD: carboxymethyl- -CD 
DASBCD: heptakis(2,6-diacetyl-6-sulfato)-β-CD 
DMBCD: heptakis(2,6-di-O-methyl)-β-CD 
DIKGA: (2)-2,3:4,6-di-O-isopropylidene-2-keto-L-gulonic acid 
DMSBCD: heptakis(2,3-di-O-methyl-6-O-sulfo)- -CD 
HPBCD: hydroxypropyl- -CD 
HSBCD: highly sulfonated -CD 
HSGCD : highly sulfated -CD 
MBCD, methyl- -CD 
PABCD: 6-monodeoxy-6-mono(3-hydroxy)propylamino- -CD 
QABCD: quaternary ammonium -CD 
SBEBCD: sulfobutyl ether β-CD 
SBCD : sulfated -CD 
SuccGCD: succinyl- -CD 
TMABCD: 2-hydroxypropyltrimethylammonium- -CD 
TMBCD: heptakis(2,3,6-tri-O-methyl)-β-CD 
18C6TCA: (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid 
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Table 3. Chiral-MEKC-MS applications. 
 
Chiral analyte Polymer1 Sample BGE composition MS Ref. 
1,1’-binaphtol poly-L-SUV Test mix 
20 mM NH4OAc, 0.20% 
(w/v) poly-L-SUV, pH 
9.2 
ESI-Q 
(-) 
[69] 
Atenolol 
Metoprolol 
Carteolol 
Pindolol 
Oxprenolol 
Talinolol 
Alprenolol 
Propanolol 
poly-L-SUCL Test mix 
25 mM each NH4OAC 
and TEA, 15 mM poly-L-
SUCL, pH 8.0, 
ESI-Q 
(+) 
[70] 
Oxazepam 
Lorazepam 
Nefopam 
poly-L-SUL 
poly-L-SUV 
poly-L-SUCL 
poly-L-SUCV 
poly-L,L-SULV 
poly-L,L-SUCLV 
Test mix 
25 mM NH4OAC, 15 mM 
poly-L,L-SUCLV, pH 8.5 
containing 10% v/v ACN 
ESI-Q 
(+) 
[71] 
Warfarin 
Coumachlor 
poly-L,L-SULV 
Human 
plasma 
25 mM NH4OAC, 25 mM 
poly-L,L-SULV, pH 6 
ESI-Q 
(-) 
[72] 
Pseudoepinephdrine poly-L-SUCLS 
Human 
urine 
15 mM NH4OAC, 15 mM 
TEA, pH 2.0 
ESI-Q 
(+) 
[73] 
Ephedrine 
Pseudoephedrine 
N-methylephedrine 
norephedrine 
poly-L-SUCL Test mix 
35 mM poly-L-SUCL, 15 
mM NH4OAc, pH 6.0 
containing 30% v/v ACN 
ESI-Q 
(+) 
[74] 
Ephedrine 
Pseudoephedrine 
N-methylephedrine 
N-methylpseudoephedrine 
Norephedrine 
Norpseudoephedrine 
poly-L-SUCL Test mix 
35 mM poly-L-SUCL, 15 
mM NH4OAc, pH 6.0 
containing 30% v/v ACN 
ESI-Q 
(+) 
[75] 
1,1’-binaphtol 
1,1’-binaphthyl-2,2’diyl 
hydrogen phosphate 
poly-L-SUCL 
poly-L,L-SULV 
Test mix 
35 mM NH4OAc, 27 mM 
surfactant, pH 10.8 
ESI-Q 
(-) 
[76] 
 
1 The polymer is used as micellar-system and chiral selector simultaneously. Abbreviations are indicated next: 
 
poly-L,L-SUCLV, polysodium N-undecenoxycarbonyl-L,L-leucyl-valinate 
poly-L,L-SULV, polysodium N- undecenoyl-L,L-leucyl-valinate 
poly-L-SUCL, polysodium N-undecenoxycarbonyl-L-leucinate 
poly-L-SUCLS, polysodium N-undecenoxycarbonyl-L-leucine sulfate 
poly-L-SUCV, polysodium N-undecenoxycarbonyl-L-valinate 
poly-L-SUL, polysodium N-undecanoyl-L-leucinate 
poly-L-SUV, poly(sodium N-undecanoyl-L-valinate) 
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Table 4. Chiral-CEC-MS applications. 
 
Chiral analyte 
Chiral selector1 
(stationary phase) 
Sample 
BGE composition 
(mobile phase) 
MS Ref. 
Hexobarbital Permethylated β-CD 
Human 
urine 
10 mM NH4OAc, pH 7 
ESI-Q 
(+) 
[77] 
Hexobarbital, 
Mephobarbital, 
Fenoxaprop ethyl 
Ciclofopmethyl 
Mecoprop 
 
Permethylated β-CD 
Test 
mixture 
0.5 mM NH4OAc in water-
metanol (40:60, v/v), pH 
6.6 
CIS-Q 
(+) 
[78] 
Warfarin 
Coumachlor 
(3R,4S)-Whelk-O1 
CSP 
Human 
plasma 
0.5 mM NH4OAc in ACN-
water (70:30, v/v), pH 4.0 
 
ESI-Q 
(-) 
[79] 
Atenolol 
Metoprolol 
Tartrate 
Pindolol 
Oxprenolol 
Talinolol 
Alprenolol 
Propranolol 
Warfarin 
Coumachlor 
Vancomycin CSP 
Test 
mixture 
MeOH-ACN (70:30, v/v) 
containing 1.6% HOAc and 
0.2% TEA 
ESI-Q 
(-) 
[80] 
Atenolol 
Metoprolol 
Pindolol 
Oxprenolol 
Talinolol 
Propranolol 
Alprenolol 
Carteolol 
Vancomycin CSP 
Teicoplanin CSP 
Multimodal CSP 
Test 
mixture 
MeOH-ACN (70:30, v/v) 
containing 1.6% HOAc and 
0.2% TEA 
ESI-Q 
(+) 
[81] 
Nadolol 
Labetalol 
Vancomycin 
Test 
mixture 
MeOH-ACN (40:60, v/v) 
containing 1.6% HOAc and 
0.4% TEA 
ESI-Q 
(+) 
[82] 
Basic, neutral  and 
acidic analytes 
6-SO4- CDMPC 
CDMPC-SO3 
Test 
mixture 
various conditions 
ESI-Q 
(+) and (-) 
[83] 
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FIGURE LEGENDS 
 
Figure 1. CE-ESI-TOF MS extracted ion electropherograms from a vinegar. Zooms of D-Ala 
and D-Leu naturally found in vinegar. (A) Vinegar sample. (B) Vinegar spiked with L-Ala and 
D-Ala. CE-MS conditions: Bare fused-silica capillary with 50 µm ID and 85 cm of total length. 
Running buffer: 50 mM ammonium hydrogen carbonate at pH 8.0, 0.5 mM 3-monodeoxy-3-
monoamino- -cyclodextrin. Running voltage: 30 kV  and 25º C. Sheath liquid: water-2-propanol 
(50:50 v/v) delivered at 0.24 mL/h. ESI polarity in the positive mode with a 0.3 bar nebulizer and 
4 L/min dry gas at 180º C [39]. 
 
Figure 2. NAEKC-MS extracted ion electropherograms of a mixture of mebeverine and five 
related compounds (20 μg/ml each). BGE: 0.75 M formic acid, 30 mM HDMS-β-CD and 30 
mM potassium camphorsulfonate [44]. 
 
Figure 3. Chiral analysis of amphetamine (A), methamphetamine (MA), 
methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), 
methylenedioxyethylamphetamine (MDEA), tramadol (TMD), and methadone (MTD) 
enantiomers at 2.5 ppm in plasma. CE-MS conditions: Bare fused-silica capillary of 75 cm x 50 
µm ID. Running voltage: +25 kV. Injection at 50 mbar x 10 s. 50% filled with HSGCD in BGE: 
20 mM ammonium formate at pH 2.5 [60]. 
 
Figure 4. MEKC-MS separation of steroisomers of ephedrine and related compounds along with 
internal standard. MEKC-MS conditions: 120 cm long fused silica capillary and 50 μm ID, 2 s 
injection at 2 mbar , 30 kV running voltage, BGE: 15 mM ammonium acetate/35 mM poly-L-
SUCL containing 30% ACN at pH 6.0. Sheath liquid: methanol/water 80:20 (v/v) containing 5 
 
 
 
40 
mM ammonium acetate delivered at 5 μL/min, dry gas at 250º C at 8 L/min, nebulizer gas 
pressure at 4 psi. Redrawn from [75]. 
 
Figure 5. CEC-ESI-MS electropherograms of warfarin and Troger’s base enantiomers with 
different modes of mobile phase using CDMPC-SO3 as stationary phase. (a and b) normal phase; 
(c and d) polar organic phase; (e and f) reversed-phase; (g) S/N plot of both compounds. 
Redrawn from [83]. 
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